Cancers, Free Full-Text

Imatinib became the standard treatment for chronic myeloid leukemia (CML) about 20 years ago, which was a major breakthrough in stabilizing the pathology and improving the quality of life of patients. However, the emergence of resistance to imatinib and other tyrosine kinase inhibitors leads researchers to characterize new therapeutic targets. Several studies have highlighted the role of histone deacetylase 6 (HDAC6) in various pathologies, including cancer. This protein effectively intervenes in cellular activities by its primarily cytoplasmic localization. In this review, we will discuss the molecular characteristics of the HDAC6 protein, as well as its overexpression in CML leukemic stem cells, which make it a promising therapeutic target for the treatment of CML.

Free PSD Breast cancer awareness editable text effect

Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization

Radical causes of cancer

Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.

Cancer Cells: Types, How They Form, and Characteristics

Detecting cell-of-origin and cancer-specific methylation features of cell- free DNA from Nanopore sequencing, Genome Biology

Artificial intelligence-aided clinical annotation of a large multi-cancer genomic dataset

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

Time trial: A prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers – topic of research paper in Clinical medicine. Download scholarly

Cancer Awareness Word Search – Free Printable

Kidney Cancer: Symptoms, Signs, Causes & Treatment

Cancer Cells vs. Normal Cells: How Are They Different?

Breast Cancer Awareness Month - National Breast Cancer Foundation